EVOLUTION METALS & TECHNOLOG (EMAT) Fundamental Analysis & Valuation

NASDAQ:EMAT • US30054B1070

Current stock price

7.45 USD
-0.35 (-4.49%)
Last:

This EMAT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. EMAT Profitability Analysis

1.1 Basic Checks

  • EMAT had negative earnings in the past year.
  • EMAT had a negative operating cash flow in the past year.
  • In the past 5 years EMAT always reported negative net income.
  • In the past 5 years EMAT always reported negative operating cash flow.
EMAT Yearly Net Income VS EBIT VS OCF VS FCFEMAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 -1M -2M -3M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -27.07%, EMAT is doing worse than 82.17% of the companies in the same industry.
Industry RankSector Rank
ROA -27.07%
ROE N/A
ROIC N/A
ROA(3y)-11.54%
ROA(5y)-7.54%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EMAT Yearly ROA, ROE, ROICEMAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 20 -20 -40 -60

1.3 Margins

  • EMAT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMAT Yearly Profit, Operating, Gross MarginsEMAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025

2

2. EMAT Health Analysis

2.1 Basic Checks

  • EMAT has less shares outstanding than it did 1 year ago.
  • The debt/assets ratio for EMAT is higher compared to a year ago.
EMAT Yearly Shares OutstandingEMAT Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
EMAT Yearly Total Debt VS Total AssetsEMAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

  • EMAT has an Altman-Z score of 222.04. This indicates that EMAT is financially healthy and has little risk of bankruptcy at the moment.
  • EMAT's Altman-Z score of 222.04 is amongst the best of the industry. EMAT outperforms 98.73% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 222.04
ROIC/WACCN/A
WACCN/A
EMAT Yearly LT Debt VS Equity VS FCFEMAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 20M 40M 60M

2.3 Liquidity

  • EMAT has a Current Ratio of 0.02. This is a bad value and indicates that EMAT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.02, EMAT is doing worse than 95.54% of the companies in the same industry.
  • A Quick Ratio of 0.02 indicates that EMAT may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.02, EMAT is not doing good in the industry: 95.54% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
EMAT Yearly Current Assets VS Current LiabilitesEMAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 2M 4M 6M 8M

0

3. EMAT Growth Analysis

3.1 Past

  • EMAT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -148.11%.
EPS 1Y (TTM)-148.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. EMAT Valuation Analysis

4.1 Price/Earnings Ratio

  • EMAT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EMAT Price Earnings VS Forward Price EarningsEMAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EMAT Per share dataEMAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. EMAT Dividend Analysis

5.1 Amount

  • EMAT has a Yearly Dividend Yield of 12.84%, which is a nice return.
  • Compared to an average industry Dividend Yield of 1.08, EMAT pays a better dividend. On top of this EMAT pays more dividend than 98.09% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.91, EMAT pays a better dividend.
Industry RankSector Rank
Dividend Yield 12.84%

5.2 History

  • EMAT is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
EMAT Yearly Dividends per shareEMAT Yearly Dividends per shareYearly Dividends per share 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
EMAT Yearly Income VS Free CF VS DividendEMAT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 2025 -500K -1M -1.5M -2M

EMAT Fundamentals: All Metrics, Ratios and Statistics

EVOLUTION METALS & TECHNOLOG

NASDAQ:EMAT (3/16/2026, 3:12:36 PM)

7.45

-0.35 (-4.49%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-20
Earnings (Next)05-04
Inst Owners0.02%
Inst Owner ChangeN/A
Ins Owners0.29%
Ins Owner Change0%
Market Cap4.42B
Revenue(TTM)N/A
Net Income(TTM)-1.79M
AnalystsN/A
Price TargetN/A
Short Float %0.3%
Short Ratio0.58
Dividend
Industry RankSector Rank
Dividend Yield 12.84%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.61
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS-0.01
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -27.07%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-11.54%
ROA(5y)-7.54%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z 222.04
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-148.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.98%
OCF growth 3YN/A
OCF growth 5YN/A

EVOLUTION METALS & TECHNOLOG / EMAT Fundamental Analysis FAQ

What is the fundamental rating for EMAT stock?

ChartMill assigns a fundamental rating of 1 / 10 to EMAT.


What is the valuation status of EVOLUTION METALS & TECHNOLOG (EMAT) stock?

ChartMill assigns a valuation rating of 0 / 10 to EVOLUTION METALS & TECHNOLOG (EMAT). This can be considered as Overvalued.


How profitable is EVOLUTION METALS & TECHNOLOG (EMAT) stock?

EVOLUTION METALS & TECHNOLOG (EMAT) has a profitability rating of 0 / 10.


How financially healthy is EVOLUTION METALS & TECHNOLOG?

The financial health rating of EVOLUTION METALS & TECHNOLOG (EMAT) is 2 / 10.